Company intelligence / Profile preview

Cycle Pharmaceuticals

Cambridge, Cambridgeshire, United Kingdomcyclepharma.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Cycle Pharmaceuticals develops and commercializes therapies for rare diseases, focusing on improving orphan drugs, repurposing existing drugs for new indications, and reinstating generics. The company has launched products in the market and maintains a pipeline targeting rare genetic disorders as well as neurological and immunological conditions. It partners with technology providers like Catalent to enhance drug delivery using advanced formulation technologies such as Zydis ODT

Therapeutic areas: ImmunologyRare DiseasesNeurologyMetabolic Disorders
Modalities: Small moleculeFormulation technology (e.g., orally disintegrating tablets)
Industry: Biotech

Drug pipeline

3 assets

monomethyl fumarate

Approved

2 more assets in the full pipeline.

Request access →

Partnerships

Catalent – partnership to use Zydis ODT fast-dissolve tablet technology in product development for rare diseasesAcademic partnerships with renowned universities globally are mentioned but not specifically named

Beyond the preview

Go deeper on Cycle Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cycle Pharmaceuticals.

Explore the full profile